Amgen Inc. (AMGN) Operating cash flow 2016–2025
Amgen Inc. (AMGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$10.0BFY2025 · since FY2016: $10.4B → $10.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0B | -13.3% |
| FY2024 | $11.5B | +35.6% |
| FY2023 | $8.5B | -12.9% |
| FY2022 | $9.7B | +5.0% |
| FY2021 | $9.3B | -11.8% |
| FY2020 | $10.5B | +14.7% |
| FY2019 | $9.2B | -19.0% |
| FY2018 | $11.3B | +1.1% |
| FY2017 | $11.2B | +7.9% |
| FY2016 | $10.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN RevenueAMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating incomeAMGN Operating marginAMGN Free cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Total liabilitiesAMGN Shareholders’ equityAMGN overview →